CLOV Stock Summary and Trading Ideas (Clover Health Investments Corp. - Class A | NASDAQ:CLOV)

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

What symbol and exchange does Clover Health Investments Corp. - Class A shares trade?

Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.

What is Clover Health Investments Corp. - Class A stock price doing today?

As of October 9, 2026, CLOV stock price climbed to $4.79 with 9,847,173 million shares trading.

What is Clover Health Investments Corp. - Class A's Beta?

CLOV has a beta of 2.97, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.22 to the broad based SPY ETF.

How much is Clover Health Investments Corp. - Class A worth?

CLOV has a market cap of $2.54 billion. This is considered a Mid Cap stock.

How much money does Clover Health Investments Corp. - Class A make?

Last quarter Clover Health Investments Corp. - Class A reported $743 million in Revenue and $.05 earnings per share. This beat revenue expectation by $15 million and exceeded earnings estimates by $.01.

What is the highest and lowest price Clover Health Investments Corp. - Class A traded in the last 3 year period?

In the last 3 years, CLOV traded as high as $5.59 and as low as $.61.

What are the top ETFs holding Clover Health Investments Corp. - Class A?

The top ETF exchange traded funds that CLOV belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.

Is Clover Health Investments Corp. - Class A (CLOV) a good investment?

CLOV has outperformed the market in the last year with a price return of +79.4% while the SPY ETF gained +17.1%. However, in the short term, CLOV had mixed performance relative to the market. It has underperformed in the last 3 months, returning +2.4% vs +3.8% return in SPY. But in the last 2 weeks, CLOV shares have fared better than the market returning +6.7% compared to SPY +0.9%.

What are the support and resistance levels for Clover Health Investments Corp. - Class A (CLOV)?

CLOV support price is $4.42 and resistance is $4.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.